Survivorship care and mortality in a contemporary and diverse cohort of childhood cancer survivors.

Xu Ji,Rebecca S Williamson Lewis,Karen Wasilewski-Masker,Karen E Effinger,Kevin C Ward,Jordan Gilleland Marchak,James L Klosky,Joseph Lipscomb,Ann C Mertens,Sharon M Castellino
{"title":"Survivorship care and mortality in a contemporary and diverse cohort of childhood cancer survivors.","authors":"Xu Ji,Rebecca S Williamson Lewis,Karen Wasilewski-Masker,Karen E Effinger,Kevin C Ward,Jordan Gilleland Marchak,James L Klosky,Joseph Lipscomb,Ann C Mertens,Sharon M Castellino","doi":"10.1093/jnci/djaf276","DOIUrl":null,"url":null,"abstract":"BACKGROUND\r\nImplementing quality survivorship care for the growing population of cancer survivors is a national priority. The impact of comprehensive survivorship care on survival among childhood cancer survivors is unknown.\r\n\r\nMETHODS\r\nThis retrospective analysis included patients eligible for receipt of a survivorship care plan (SCP) in the institutional survivorship program at a comprehensive pediatric cancer center following initial diagnosis between 2002-2016. We followed survivors from eligibility to 10 years, death, or December 31, 2020, whichever occurred earliest. Cox proportional hazards models estimated the association of SCP receipt at an initial survivorship program visit with overall survival (OS) and event-free survival (EFS), adjusting for sociodemographic and cancer-related factors.\r\n\r\nRESULTS\r\nAmong 3,366 survivors, 1,883 (55.9%) received a SCP, at median of 0.67 years (interquartile range [IQR]=0.30-1.67) post-eligibility. Compared to those who received a SCP, survivors without were more likely to be older at eligibility (mean age [standard deviation] 11.8 [6.1] vs 11.2 [5.5] years, p = .002), non-Hispanic Black (29.5% vs 24.8%, p = .006), treated for central nervous system tumors (38.7% vs 12.4%, p < .001), or treated with surgery only (46.8% vs 1.2%, p < .001). Overall, 2.9% of survivors died at a median of 3.6 years (IQR = 2.3-5.4) from eligibility. In multivariable models, SCP receipt (vs non-receipt) was associated with a lower risk of death (OS adjusted hazard ratio [aHR]=0.62, 95% CI = 0.39-0.97, p = .04; EFS: aHR = 0.73, 95% CI = 0.54-0.99, p = .04).\r\n\r\nCONCLUSION\r\nEngagement in survivorship care, indicated by SCP receipt, was associated with superior overall and event-free survival in childhood cancer survivors, underscoring its importance in improving long-term outcomes.","PeriodicalId":501635,"journal":{"name":"Journal of the National Cancer Institute","volume":"64 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the National Cancer Institute","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jnci/djaf276","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND Implementing quality survivorship care for the growing population of cancer survivors is a national priority. The impact of comprehensive survivorship care on survival among childhood cancer survivors is unknown. METHODS This retrospective analysis included patients eligible for receipt of a survivorship care plan (SCP) in the institutional survivorship program at a comprehensive pediatric cancer center following initial diagnosis between 2002-2016. We followed survivors from eligibility to 10 years, death, or December 31, 2020, whichever occurred earliest. Cox proportional hazards models estimated the association of SCP receipt at an initial survivorship program visit with overall survival (OS) and event-free survival (EFS), adjusting for sociodemographic and cancer-related factors. RESULTS Among 3,366 survivors, 1,883 (55.9%) received a SCP, at median of 0.67 years (interquartile range [IQR]=0.30-1.67) post-eligibility. Compared to those who received a SCP, survivors without were more likely to be older at eligibility (mean age [standard deviation] 11.8 [6.1] vs 11.2 [5.5] years, p = .002), non-Hispanic Black (29.5% vs 24.8%, p = .006), treated for central nervous system tumors (38.7% vs 12.4%, p < .001), or treated with surgery only (46.8% vs 1.2%, p < .001). Overall, 2.9% of survivors died at a median of 3.6 years (IQR = 2.3-5.4) from eligibility. In multivariable models, SCP receipt (vs non-receipt) was associated with a lower risk of death (OS adjusted hazard ratio [aHR]=0.62, 95% CI = 0.39-0.97, p = .04; EFS: aHR = 0.73, 95% CI = 0.54-0.99, p = .04). CONCLUSION Engagement in survivorship care, indicated by SCP receipt, was associated with superior overall and event-free survival in childhood cancer survivors, underscoring its importance in improving long-term outcomes.
当代儿童癌症幸存者的生存护理和死亡率。
背景:为不断增长的癌症幸存者提供高质量的生存护理是国家的优先事项。综合生存护理对儿童癌症幸存者生存的影响尚不清楚。方法回顾性分析了2002-2016年在一家综合儿科癌症中心接受初步诊断的机构生存计划中符合接受生存护理计划(SCP)的患者。我们对幸存者进行随访,从符合条件到10岁、死亡或2020年12月31日,以较早发生的为准。Cox比例风险模型估计了初始生存计划访问时SCP接收与总生存期(OS)和无事件生存期(EFS)的关联,调整了社会人口统计学和癌症相关因素。结果在3366名幸存者中,1883名(55.9%)接受了SCP治疗,中位时间为0.67年(四分位间距[IQR]=0.30-1.67)。与接受过SCP的患者相比,没有接受过SCP的患者更有可能在资格时年龄更大(平均年龄[标准差]11.8[6.1]比11.2[5.5]岁,p =。002),非西班牙裔黑人(29.5% vs 24.8%, p =。006),治疗中枢神经系统肿瘤(38.7% vs 12.4%, p < 0.05)。0.001),或仅接受手术治疗(46.8% vs 1.2%, p < 0.001)。总体而言,2.9%的幸存者在平均3.6年(IQR = 2.3-5.4)死亡。在多变量模型中,接受SCP(与未接受SCP相比)与较低的死亡风险相关(经OS校正的风险比[aHR]=0.62, 95% CI = 0.39-0.97, p = 0.04; EFS: aHR = 0.73, 95% CI = 0.54-0.99, p = 0.04)。结论:接受SCP治疗表明,参与生存护理可提高儿童癌症幸存者的总体生存率和无事件生存率,强调其对改善长期预后的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信